Literature DB >> 18045565

Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki Eye Study.

Fotis Topouzis1, Anne L Coleman, Alon Harris, Archimidis Koskosas, Panayiota Founti, Gordon Gong, Fei Yu, Eleftherios Anastasopoulos, Theofanis Pappas, M Roy Wilson.   

Abstract

PURPOSE: To identify factors associated with undiagnosed open-angle glaucoma (OAG), primary open-angle glaucoma (POAG), and pseudoexfoliative glaucoma (PEXG) in an elderly population in Thessaloniki, Greece.
DESIGN: Cross-sectional population-based study.
METHODS: Randomly selected subjects > or =60 years (n = 2,554) participated in the study. Subjects were classified as having POAG or PEXG according to specific criteria and using a two-scale definition of glaucoma. Undiagnosed glaucoma was defined as absence of either prior diagnosis of glaucoma or ocular hypertension or prior medical treatment for glaucoma or prior glaucoma surgery. Logistic regression analyses were performed with age, gender, family history of glaucoma, history of cataract surgery, visual acuity, vertical cup-to-disk (C/D) ratio, intraocular pressure, Advanced Glaucoma Intervention Study visual field score, time since last eye doctor visit, and type of OAG as covariates.
RESULTS: The prevalence of undiagnosed glaucoma was 57.1% (56/98) for POAG, significantly higher than the prevalence of 34.9% (15/43) for PEXG (P = .017). POAG patients presented three to four times increased risk to be undiagnosed compared with PEXG patients (P = .02 and P = .04, respectively). Patients with OAG who had not visited an ophthalmologist during the last year had six times an increased risk to be undiagnosed (P = .003). In POAG, smaller vertical C/D ratio was statistically significantly associated with an increased risk to be undiagnosed (P = .008).
CONCLUSIONS: Lack of regular visits to an ophthalmologist was a major factor for undiagnosed OAG. POAG was more likely to be undiagnosed than PEXG. Since C/D ratio was associated with undiagnosed POAG, standardized protocols involving thorough evaluation of the optic disk are recommended for ophthalmologists.

Entities:  

Mesh:

Year:  2007        PMID: 18045565     DOI: 10.1016/j.ajo.2007.09.013

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  23 in total

1.  Why Do People (Still) Go Blind from Glaucoma?

Authors:  Remo Susanna; Carlos Gustavo De Moraes; George A Cioffi; Robert Ritch
Journal:  Transl Vis Sci Technol       Date:  2015-03-09       Impact factor: 3.283

2.  [Glaucoma diseases in Rhineland-Palatine 2010. Epidemiology and utilization of healthcare].

Authors:  C Wolfram; N Pfeiffer
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

3.  Glaucoma public service announcements: factors associated with follow-up of participants with risk factors for glaucoma.

Authors:  Zakary Hoffelt; Shawn Fallon; Brad A Wong; Betty Lucas; Anne L Coleman; Richard P Mills; Richard Wilson; Steven L Mansberger
Journal:  Ophthalmology       Date:  2011-03-24       Impact factor: 12.079

4.  Improving Access to Eye Care among Persons at High-Risk of Glaucoma in Philadelphia--Design and Methodology: The Philadelphia Glaucoma Detection and Treatment Project.

Authors:  Lisa Hark; Michael Waisbourd; Jonathan S Myers; Jeffrey Henderer; John E Crews; Jinan B Saaddine; Jeanne Molineaux; Deiana Johnson; Harjeet Sembhi; Shayla Stratford; Ayman Suleiman; Laura Pizzi; George L Spaeth; L Jay Katz
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

5.  Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database.

Authors:  Renato De Natale; Antoine Lafuma; Gilles Berdeaux
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

6.  Prevalence and severity of undetected manifest glaucoma: results from the early manifest glaucoma trial screening.

Authors:  Anders Heijl; Boel Bengtsson; Sigridur Erla Oskarsdottir
Journal:  Ophthalmology       Date:  2013-04-28       Impact factor: 12.079

7.  Treatment persistence and cost-effectiveness of latanoprost/latanoprost-timolol, bimatoprost/bimatoprost-timolol, and travoprost/travoprost-timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database.

Authors:  Antoine Lafuma; John F Salmon; Julien Robert; Gilles Berdeaux
Journal:  Clin Ophthalmol       Date:  2011-03-14

Review 8.  Cyclodestructive procedures for non-refractory glaucoma.

Authors:  Manuele Michelessi; Amanda K Bicket; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2018-04-25

Review 9.  Deep learning in glaucoma with optical coherence tomography: a review.

Authors:  An Ran Ran; Clement C Tham; Poemen P Chan; Ching-Yu Cheng; Yih-Chung Tham; Tyler Hyungtaek Rim; Carol Y Cheung
Journal:  Eye (Lond)       Date:  2020-10-07       Impact factor: 3.775

10.  Effectiveness of Elevated Intraocular Pressure as a Criterion for Glaucoma Referral After 6 Years of Follow-Up.

Authors:  Andreas G Nilsson; Dorothea Peters
Journal:  Clin Ophthalmol       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.